Despite the drag of the omicron variant and falling short of consensus expectations, Edwards Lifesciences finished off the full year very close to our projections, and we’re leaving our fair value ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Edwards Lifesciences Corp. is currently ...
Hosted on MSN
Edwards Lifesciences’ New Study on Continuous Blood Pressure Monitoring: What Investors Should Know
Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Edwards Lifesciences experienced some regional pressures, and pricing was maintained. Edwards Lifesciences agreed to acquire Endotronix and JenaValve for $1.2 billion. Get access to the leaderboards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback